Comparing Ibrutinib vs Leukeran
| Ibrutinib | Leukeran (chlorambucil) |
|
|---|
| Ibrutinib | Leukeran (chlorambucil) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Ibrutinib is an oral tablet that may be taken once daily to treat certain types of cancers in adults or to treat chronic Graft Versus Host disease in adults and children older than 1 year. It works... View more |
Prescription only
Prescribed for Cancer, Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Lymphoma. Leukeran may also be used for purposes not listed in this medication guide. |
Related suggestions Popular comparisons
|
|||||||
| More about Ibrutinib | More about Leukeran (chlorambucil) | ||||||||
| Ratings & Reviews | |||||||||
|
Ibrutinib has an average rating of 6.9 out of 10 from a total of 87 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 26% reported a negative effect. |
Leukeran has an average rating of 8.7 out of 10 from a total of 3 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Ibrutinib side effects |
View all Leukeran side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Leukeran prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Imbruvica |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
6 hours |
2 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 510 drugs are known to interact with Ibrutinib:
|
A total of 270 drugs are known to interact with Leukeran:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
November 13, 2013 |
March 18, 1957 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.